A preclinical study on the rescue of normal tissue by nicotinic acid in high-dose treatment with APO866, a specific nicotinamide phosphoribosyltransferase inhibitor.

Source:http://linkedlifedata.com/resource/pubmed/id/20515945

Download in:

View as

General Info

PMID
20515945